UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

Psychopharmacology, 1996-03, Vol.124 (1-2), p.168-175

1996

Volltextzugriff (PDF)

Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes

Psychiatry research, 2000-02, Vol.93 (1), p.33-39

2000

Volltextzugriff (PDF)

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

Biological psychiatry (1969), 1989-06, Vol.26 (2), p.176-188

1989

Volltextzugriff (PDF)

Amphetamine and negative symptoms of schizophrenia

Psychopharmacologia, 1996, Vol.123 (2), p.211-214

1996

Volltextzugriff (PDF)

Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients

Neuropsychopharmacology (New York, N.Y.), 1996-04, Vol.14 (4), p.275-283

1996

Volltextzugriff (PDF)

Chronic haloperidol treatment does not affect structure of attention in schizophrenia

Schizophrenia research, 1997-05, Vol.25 (1), p.53-61

1997

Volltextzugriff (PDF)

Clonidine treatment of schizophrenia: Can we predict treatment response?

Psychiatry research, 1989-03, Vol.27 (3), p.297-311

1989

Volltextzugriff (PDF)

Predicting haloperidol treatment response in chronic schizophrenia

Psychiatry research, 1996-08, Vol.64 (1), p.47-58

1996

Volltextzugriff (PDF)

Neuropsychiatric Symptoms Associated with Idiopathic Calcification of the Basal Ganglia

The journal of nervous and mental disease, 1991-01, Vol.179 (1), p.48-49

1991

Volltextzugriff (PDF)

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Archives of general psychiatry, 1997-01, Vol.54 (1), p.49

1997

Volltextzugriff (PDF)

Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients

The American journal of psychiatry, 1985-01, Vol.142 (1), p.78-81

1985

Volltextzugriff (PDF)

CSF chromogranin A-like immunoreactivity in schizophrenia: Assessment of clinical and biochemical relationships

Schizophrenia research, 1991-12, Vol.6 (1), p.31-39

1991

Volltextzugriff (PDF)

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

The American journal of psychiatry, 1981-11, Vol.138 (11), p.1457-1462

1981

Volltextzugriff (PDF)

CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study

European archives of psychiatry and clinical neuroscience, 1994-11, Vol.244 (4), p.216-222

1994

Volltextzugriff (PDF)

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

Psychiatry research, 1992-04, Vol.42 (1), p.53-63

1992

Volltextzugriff (PDF)

d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia

The American journal of psychiatry, 1982-08, Vol.139 (8), p.991-997

1982

Volltextzugriff (PDF)

Immunoglobulins and Viral Antibodies in Psychiatric Patients

British journal of psychiatry, 1978-04, Vol.132 (4), p.342-348

1978

Volltextzugriff (PDF)

Smooth pursuit eye movement disorder and its psychobiologic correlates in unmedicated schizophrenics

Biological psychiatry (1969), 1986-10, Vol.21 (12), p.1167-1174

1986

Volltextzugriff (PDF)

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

The American journal of psychiatry, 1979-05, Vol.136 (5), p.685-687

1979

Volltextzugriff (PDF)

Diazepam in schizophrenia: a preliminary double-blind trial

The American journal of psychiatry, 1982-04, Vol.139 (4), p.489-491

1982

Volltextzugriff (PDF)

Patient and Family Attitudes About Schizophrenia: Implications for Genetic Counseling

Schizophrenia bulletin, 1982, Vol.8 (3), p.504-513

1982

Volltextzugriff (PDF)

Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia

Archives of general psychiatry, 1995-08, Vol.52 (8), p.673

1995

Volltextzugriff (PDF)

alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs

Archives of general psychiatry, 1983-03, Vol.40 (3), p.264

1983

Volltextzugriff (PDF)

Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone

Psychiatry research, 1979-01, Vol.1 (1), p.61-69

1979

Volltextzugriff (PDF)

Computed tomographic scans in patients with schizophrenia, schizoaffective, and bipolar affective disorder

Archives of general psychiatry, 1983-07, Vol.40 (7), p.735

1983

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

ThemaPsychopathology. Psychiatry

ThemaPsychiatry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(30)
Male
(27)
Adult
(26)
Middle Aged
(16)
Schizophrenia - Drug Therapy
(16)
Schizophrenic Psychology
(16)
Female
(15)
Schizophrenia
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Psychiatric Status Rating Scales
(11)
Neuropharmacology
(10)
Pharmacology. Drug Treatments
(10)
Psychology. Psychoanalysis. Psychiatry
(10)
Psychopharmacology
(10)
Psycholeptics: Tranquillizer, Neuroleptic
(9)
Schizophrenia - Cerebrospinal Fluid
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia

Influence of haloperidol on the relationship of frontal lobe function to psychomotor poverty and disorganization syndromes

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

Amphetamine and negative symptoms of schizophrenia

Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients

Chronic haloperidol treatment does not affect structure of attention in schizophrenia

Clonidine treatment of schizophrenia: Can we predict treatment response?

Predicting haloperidol treatment response in chronic schizophrenia

Neuropsychiatric Symptoms Associated with Idiopathic Calcification of the Basal Ganglia

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients

CSF chromogranin A-like immunoreactivity in schizophrenia: Assessment of clinical and biochemical relationships

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia

Immunoglobulins and Viral Antibodies in Psychiatric Patients

Smooth pursuit eye movement disorder and its psychobiologic correlates in unmedicated schizophrenics

Reduced cyclic AMP production in the blood platelets from schizophrenic patients

Diazepam in schizophrenia: a preliminary double-blind trial

Patient and Family Attitudes About Schizophrenia: Implications for Genetic Counseling

Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia

alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs

Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone

Computed tomographic scans in patients with schizophrenia, schizoaffective, and bipolar affective disorder

Aktive Filter

Suchergebnisse filtern